[Seite 88↓]

Literaturverzeichnis

1. R. Dengler, S. Zierz, F. Jerusalem: Amyotrophe Lateralsklerose, Georg Thieme Verlag Stuttgart; 1994

2. J.M. Charcot : De la sclérose latérale amyotrophique ; Prog Med 2 ; 325-327 ; 1874

3. L.M. Nelson, V. McGuire, W.T. Longstreth, C. Matkin: Population-based case-control study of amyotrophic lateral sclerosis in Western Washington State. Cigarette smoking and alcohol consumption; Am J Epidemiol 151(2); 156-163; 2000

4. H. Mitsumoto, M.R. Hanson, D.A. Chad: Amyotrophic lateral sclerosis: recent advantages in pathogenesis and therapeutic approaches; Arch Neurol 45;189-202; 1988

5. L. P. Rowland: Motor neuron disease and amyotrophic lateral sclerosis: research progress; TINS 10(10); 393-398; 1987

6 . R.G. Smith, L. Siklos, M.E. Alexianu, J.I. Engelhardt, D.R. Mosier, L. Colom, A. Habib Mohamed, S.H. Appel: Autoimmunity and ALS; Neurology 47(4); 40-45; 1996

7 . M.R. Ciriolo, A. De Martino, E. Lafavia, L. Rossi, M.T. Carri, G. Rotilio: Cu,Zn-superoxide dismutase dependent apoptosis induced by nitric oxide in neuronal cells; J Biol Chem 275(7); 5065-5072; 2000

8. L.J. Martin: Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death; J Neuropathol Exp Neurol 58(5); 459-471; 1999

9. P.S. Spencer, A.C. Ludolph et al: Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin; Science 237(4814); 517-522; 1987

10. R. Bachus, A. Claus, T. Meyer, M. Riepe, A.C. Ludolph: Molekularbiologische Befunde bei der amyotrophen Lateralsklerose; Der Nervenarzt 68 ; 785-791; 1997

11. A.C. Ludolph, T. Meyer, M.W. Riepe: The role of excitotoxicity in ALS-what is the evidence ? J Neurol 247; 7-16; 2000

12 . M. Dragunow, G.A. MacGibbon, P. Lawlor, N. Butterworth, B. Connor, C. Henderson, M. Walton, A. Woodgate, P. Hughes, R.L. Faull: Apoptosis, neurotrophic factors and neurodegeneration; Rev Neurosci 8(3-4); 223-265; 1997

13 . B. Connor, M. Dragunow: The role of neuronal growth factors in neurodegenerative disorders of the human brain; Brain Res Brain Res Rev 27(1); 1-39; 1998

14 . J.D. Rothstein, L.J. Martin, R.W. Kuncl: Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis; N Eng J Med 326(22); 1464-1468; 1992


[Seite 89↓]

15 . R.R. Roos, T. Siddique, J.A. Trainer: Summary of SOD and free radicals in ALS and neurodegeneration conference; Neurology 45; 1779-1780; 1995

16 . J.D. Rothstein, M. Van Kammen, A.I. Levey, L.J. Martin, R.W. Kuncl: Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis; Ann Neurol 38(1); 73-84; 1995

17 . M. Aoki, C.L. Lin, J.D. Rothstein, B.A. Geller, B.A. Hosler, T.L Munsat, H.R. Horvitz, R.H. Brown: Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis; Ann Neurol 43(5); 645-653; 1998

18 . T. Meyer, A. Speer, B. Meyer, W. Sitte, G. Küther, A.C. Ludolph: The glial glutamate transporter DNA in patients with amyotrophic lateral sclerosis; Ann Neurol 40; 456-459; 1996

19 . T. Meyer, A. Fromm, C. Munch, B. Schwalenstocker, A.E. Fray, P.G. Ince, S. Stamm, G. Gron, A.C. Ludolph, P.J. Shaw: The RNA of the glutamate transporter EAAT2 is variably spliced in amyotrophic lateral sclerosis and normal individuals; J Neurol Sci 170(1); 45-50; 1999

20.M. Jackson, G. Steers, P.N. Leigh, K.E. Morrison; Polymorphisms in the glutamate transporter gene EAAT2 in european ALS patients; J Neurol 246(12); 1140-1144; 1999

21 . T.P. Obrenovitch, J. Urenjak, E. Zilkha, T.M. Jay: Excitotoxicity in neurological disorders – the glutamate paradox; Int J Dev Neurosci 18(2-3); 281-287; 2000

22 . A.C. Ludolph, T. Meyer, M.W. Riepe: Antiglutamate therapy of ALS- wich is the next step? J Neural Transm Suppl 55; 79-95; 1999

23. G.C. Tsai, B. Stauch-Slusher, L. Sim, J.C. Hedreen, J.D: Rothstein, R. Kuncl, J.T. Coyle: Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis; Brain Res 556(1); 151-156; 1991

24. C. Krieger, R.A. Lanius, S.L. Pelech, C.A. Shaw: Amyotrophic lateral sclerosis: the involvement of intracellular Ca2+ and protein kinase C; Trends Pharmacol Sci 17(3); 114-120; 1996

25. J. B. Schulz, J. Lindenau, J. Seyfried, J Dichgans: Glutathione, oxidative stress and neurodegeneration; Eur. J. Biochem 267 (16); 4904-4911; 2000

26 . F. Facchinetti, V.L. Dawson, T.M. Dawson: Free radicals as mediators of neuronal injury; Cell Mol Neurobiol 18(6); 667-682; 1998

27. D. J. Waggoner, T. B. Bartnikas, J.D. Gitlin: The role of copper in neurodegenerative disease; Neurobiol Dis 6 (4); 221-230; 1999

28 . M.E. Gurney, H. Pu, A.Y. Chiu, M.C. Dal Canto, C.Y. Polchow, D.D. Alexander, J. Caliendo, A. Hentati, Y.W. Kwon, H.-X. Deng, W. Chen, P. Zhai, R.L. Sufit, T. Siddique: Motor neuron degeneration in mice that express a human Cu/Zn superoxide dismutase mutation; Science 264;1772-1775; 1994


[Seite 90↓]

29 . M. Bogdanov, R.H. Brown, W. Matson, R. Smart, D. Hayden, H. O´Donnell, M.F. Beal, M. Cudkowicz: Increased oxidative damage to DNA in ALS patients; Free Radical Biology and Medicine 29(7); 652-658; 2000

30 . R. G. Smith, Y.K. Henry, M.P. Mattson, S.H. Appel: Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis; Ann Neurol 44(4); 696-699; 1998

31 . W.A. Pedersen, W. Fu, J.N. Keller, W.R. Markesbery, S. Appel, R.G. Smith, E. Kasarskis, M.P. Mattson: Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients; Ann Neurol 44(5); 819-824; 1998

32 . H. Lovschall, M. Kassem, L. Mosekilde : Apoptosis: molecular aspects; Nord Med 112(8); 271-275; 1997

33 . L.J. Martin, A.C. Price, A. Kaiser, A.Y. Shaikh, Z. Liu: Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review); Int J Mol Med 5(1); 3-13; 2000

34 . B.P. He, M.J. Strong: Motor neuronal death in sporadic amyotrophic lateral sclerosis is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits; Neuropathology and applied Neurobiology 26(2); 150-160; 1999

35 . R.J. Reiter, J Cabrera, R.M. Sainz, J.C. Mayo, L.C. Manchester, D.X. Tan: Melatonin as a pharmagological argent against neuronal loss in experimental models of Huntigton´s disease, Alzheimer´s disease and parkinsonism; Ann N Y Sci 890; 471-485; 1999

36 . D. Liu, R. Yang, X. Yan, D.J. McAdoo: Hydroxyl radicals generated in vivo kill neurons in the rat spinal cord: electrophysiological, histological and neurochemical results; J Neurochem 62(1); 37-44; 1994

37 . T. Siddique, D.A. Figlewicz, M.A. Pericak-Vance, J.L. Haines, G. Rouleau, A.J. Jeffers, P. Sapp, W.-Y. Hung, J. Bebout, J. McKena-Yasek, G. Deng, H.R. Horvitz, J.F. Gusella, R.H. Brown, A.D. Roses et al.: Linkage of a gene causing amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic locus heterogenity; N Eng J Med 324; 1381-1384; 1991

38 . D. Liu, J. Wen, J. Liu, L. Li: The roles of free radicals in amyotrophic lateral sclerosis. Reactive oxygen species and elevated oxidation of protein, DNA and membrane phospholipids; Faseb J 13; 2318-2328; 1999

39 . M. Jackson, A. Al-Chalabi, Z.E. Enayat, B. Chioza, P. N. Leigh, K.E. Morrison: Copper/Zink superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation; Ann Neurol 42(5); 803-807; 1997

40 . H.X. Deng, A. Hentati, J.A. Tainer, Z. Iqbal, A. Cayabyab, W.Y. Hung, E.D. Getzoff, P. Hu, B. Hertzfeld, R.P. Roos et al: Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase; Science 261(5124); 1047-1051; 1993


[Seite 91↓]

41 . A.C. Bowling, J.B. Schulz, R.H. Brown, M.F. Beal: Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis; J Neurochem 61(6); 2322-2325; 1993

42 .P.M. Andersen, P. Nilsson, L. Forsgren, S.L. Marklund: Cu/Zn-superoxide dismutase, extracellular glutathione peroxidase in blood from individuals homozygous for Asp90Ala Cu/Zn-superoxide dismutase mutation; J Neurochem 70; 715-720 ; 1998

43 . R. Moumen, A. Nouvelot, D. Duval, B. Lechevalier, F. Viader: Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis; J Neurol Sci 151(1); 35-39; 1997

44 . S. Przedborski, D.M. Donaldson, P.L Murphy, O. Hirsch, D. Lange, A.B. Naini, D. McKenna-Yasek, R.H. Brown: Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis; Neurodegeneration 5(1); 57-64; 1996

45 . K. Fujita, M. Yamauchi, K. Shibayama, M. Ando, M. Honda, Y. Nagata: Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxidase activities in the spinal cords of patients with amyotrophic lateral sclerosis; J Neurosci Res 45(3); 276-281; 1996

46 . D. Bonnefort-Rousselot, L. Lacomblez, M.-C. Jaudon, S. Lepage et al.: Blood oxidative stress in amyotrophic lateral sclerosis ; J Neurol Sci 178(1); 57-62; 2000

47 . G.F. van Landeghem, P. Tabatabaie, G. Beckmann, L. Beckmann, P.M. Andersen: Manganese-containing superoxide dismutase signal sequence polymorphism associated with sporadic motor neuron disease; Eur J Neurol 6(6); 639-644; 1999

48 . G. McEachern, S. Kassovska-Bratinova, S. Raha, M.A. Tarnopolsky, J. Turnbull, J. Bourgeois, B. Robison: Manganese superoxide dismutase levels are elevated in a proportion of amyotrophic lateral sclerosis patient cell lines; Biochemical and Biophysical Research Comm 273; 2000

49. G.L. Squadrito, W.A. Pryor: Oxidative chemistry of nitric oxide: the roles of superoxide, peroxynitrite and carbon dioxide; Free Radic Biol Med 25(4-5); 392-403; 1998

50 . F. Torreilles, S. Salman-Tabcheh, M.-C. Guérin, J. Torreilles: Neurodegenerative disorders: the role of peroxynitrite; Brain Research Reviews 30; 153-163; 1999

51 . A.G. Estevez, N. Spear, S.M. Manuel, L. Barbeito, R Radi, J.S. Beckman: Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture; Prog Brain Res 118; 269-280; 1998

52 . A. H. Cross, P.T. Manning, M.K. Stern, T.P. Misko: Evidence for the production of peroxynitrite in inflammatory CNS demyelination; J Neuroimmunol 80(1-2); 121-130; 1997


[Seite 92↓]

53. L.I. Bruijn, M.F. Beal, M.W. Becher, J.B. Schulz, P.C. Wong, D.L. Price, D. W. Cleveland: Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout amyotrophic lateral sclerosis-like diseases implicate tyrosine nitration as an abberant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant; Proc Natl Acad Sci 94(14); 7606-7611; 1997

54 . J.P. Crow, J.B. Sampson, Y. Zhuang, J.A. Thompson, J.S. Beckman: Decreased zinc affinity of amyotrophic lateral sclerosis-associated superoxide dismutase mutants leads to enhanced catalysis of tyrosine nitration by peroxynitrite; J Neurochem 69(5 ); 1936-1944; 1997

55 . K. Abe, L.H. Pan, M. Watanabe, H. Konno, T. Kato, Y. Itoyama: Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis; Neurol Res 19(2); 124-128; 1997

56 . K. Abe, L.H. Pan, M. Watanabe, T. Kato, Y. Itoyama: Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis; Neurosci Lett 199(2); 152-154; 1995

57 . H. Tohgi, T. Abe, K. Yamazaki, T. Murata, E. Ishizaki, C. Isobe: Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis; Ann Neurol 46(1); 129-131; 1999

58 . G.F. Weber: Final common pathways in neurodegenerative diseases: regulatory role of the glutathione cycle; Neurosci Biobehav Rev 23(8); 1079-1086; 1999

59 . J.S. Bains, C.A. Shaw: Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death; Brain Res Brain Res Rev 25(3); 335-358; 1997

60 . M.E. Cudkowicz, P.M. Sexton, T. Ellis, D.L. Hayden, P.R. Gwilt, J. Whalen, R.H. Brown: The pharmakokinetics and pharmaco-dynamics of procysteine in amyotrophic lateral sclerosis; Neurology 52; 1492-1494; 1999

61 . P. Riederer, E. Sofic, W.D. Rausch, B. Schmidt, G.P. Reynolds, K. Jellinger, M.B. Youdim: Transition metals, ferritin, glutathione and ascorbic acid in parkinsonian brains; J Neurochem 52; 515-520; 1989

62 . R.A. Lanius, C. Krieger, R. Wagey, C.A. Shaw: Increased 35s glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis; Neurosci Lett 163(1); 89-92; 1993

63 . A. Chio, A. Cucatto, A.A. Terreni, D. Schiffer: Reduced glutathione in amyotrophic lateral sclerosis: an open, crossover, randomized trial; Ital J Neurol Sci 19(6); 363-366; 1998

64 . S. Chada, M.M. Le Beau, L. Casey, P.E. Newburger: Isolation and chromosomal location of the human glutathione peroxidase gene; Genomics 6; 268-271; 1990

65 . S. Apostolski, Z. Marinkovic, A. Nikolic, D. Blagojevic, M.B. Spasic, A.M. Michelson: Glutathione peroxidase in amyotrophic lateral sclerosis: the effects of selenium supplementation; J Environ Pathol Toxicol Oncol 17(3-4); 325-329; 1998

66 . S. Przedborski, D. Donaldson, M. Jakowec, S.J. Kish, M. Guttmann, G. Rosoklija, A.P. Hays: Brain superoxide dismutase, catalase and glutathione peroxidase activities in ALS; Ann Neurol 9; 158-165; 1996


[Seite 93↓]

67 . P.G. Ince, P.J. Shaw, J.M. Candy et al.: Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease; Neurosci Lett 182; 87-90; 1994

68 . M.J. Bullido, F. Valdivieso: Apolipoprotein E gene promoter polymorphisms in Alzheimer´s disease; Microsc Res Tech 50(4); 261-267; 2000

69 . L. Lannfeldt, C. Nordstedt: Genetics of Alzheimer´s Disease – routes to the pathophysiology; J Neural Transm Suppl 59; 155-161; 2000

70 . A. Al-Chalabi, Z.E. Enayat, M.C. Bakker, P.C. Sham, D.M. Ball, C.E. Shaw, C. M. Lloyd, J.F. Powell, P. N. Leigh: Association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease; Lancet 347(8995); 159-160; 1996

71 . C. Hayward, S. Colville, R.J. Swingler, D.J. Brock: Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis ; Neurology 52(9); 1899-1901; 1999

72 . Z. Xu, L.C. Cork, J.W. Griffin, D.W. Cleveland: Increased expression of neurofilament subunit NF-L produces morphological alterations that resemble the pathology of human motor neuron disease; Cell 73; 23-33; 1993

73 . J.F. Collard, F. Cote, J.P. Julien : Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis; Nature 375(6526); 61-64; 1995

74 . D. Janet, B.S. Vechio, L.I. Bruijn, Z. Xu, R.H. Brown, D.W. Cleveland: Sequence variants in human neurofilament proteins: absence of linkage to familial ALS; Ann Neurol 40(4); 603-610; 1996

75. L.Stryer: Biochemie; Spektrum Akademischer Verlag; Heidelberg, Berlin, New York; 1991

76 . S.C. Harry: Slipped structures in DNA triplet repeat sequences: entropic contributions to genetic instabilities; Biochemistry 36(11); 3047-3049; 1997

77 . C. Neri, V. Albanése, A.-S. Lebre, S. Holbert, C. Saada, L. Bougueleret, S. Meier-Ewert, I. Le Gall, P. Millasseau et al: Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for neurological disorders; Hum Mol Genet 5(7); 1001-1009; 1996

78 . A. Abel, A. Danek, G.D. Borasio, Th.N. Witt: X-chromosomal bulbospinal neuronopathy ( Kennedy-Syndrom ): a disorder with repetitive triplet sequences. Case studies, differantial diagnosis and molecular genetic aspects; Nervenarzt 67; 1011-1019; 1996

79 . W.S. Watkins, M. Bamshad, L.B. Jorde: Population genetics of trinukleotide repeat polymorphism; Hum Mol Genet 4 (9); 1485-1491; 1995

80. S. Igarashi, Y. Tanno, O. Onodera, M. Yamazaki, S. Sato, A. Ishikawa, N. Miyatani, M. Nagashima et al.: Strong correlations between the number of CAG repeats in androgen rezeptor genes and the clinical onset of features of spinal and bulbar muscular atrophy; Neurology 42; 2300-2302; 1992


[Seite 94↓]

81 . A.R. La Spada, H.L. Paulsen, K.H. Fischbeck: Trinucleotide repeat expansion in neurological disease; Ann Neurol 36; 814-822; 1994

82 . Q. Shen, P.L. Townes, C. Padden, P.E. Newburger: An in-frame trinucleotide repeat in the coding region of the human gluathione peroxidase ( GPX1) gene: in vivo polymorphism and in vitro instability; Genomics 23; 292-294; 1994

83 . A.E.H. Emery: Population frequencies of neuromuscular diseaes II. Amyotrophic lateral sclerosis (motor neurone disease); Neuromusc Disord 1; 323; 1991

84 . J.F. Kurtzke: Risk factors in amyotrophic lateral sclerosis. In L.P. Rowland : Advances in Neurology, Vol. 56: Amyotrophic lateral sclerosis and other motor neuron diseases; Raven Press; New York; 245; 1991

85 . R.D. Currier, D.E. Conwill: Influenza and physikal activities as possible risk factors for amyotrophic lateral sclerosis; a study of twins. In F.C. Rose, F.H. Norris; Amyotrophic lateral sclerosis; Smith Gordon, Nishimura; 23; 1990

86 . R.A. Dengler, S. Konstanzer, S. Hesse, M. Schubert, W. Wolf: Collateral nerve sprouting and twitch forces of single motor neuron units in conditions with partial denervation in man; Neurosci Lett 97; 118-122; 1989

87 . L.P. Rowland, R. Defendini, W.H. Sherman, A. Hirano, M.R. Olarte, N. Latov, R.E. Lovelace, K. Inoue, E.F. Osserman: Macroglobulinemia with peripheral neuropathy simulating motor neuron disease; Ann Neurol 11; 532; 1981

88. J.M. Matés, F. Sanchez-Jimenéz: Antioxidant enzymes and their implications in pathophysiologic processes; Frontieres in Bioscience 4; 339-345; 1999

89 . D. Pearson, J. Suarez-Mendez, J.P. Day, P.F. Miller: Selenium status in relatively reduced glutathione peroxidase activity in aspirin-sensitive asthma; Clin Exp Allergy 14(2); 145-148; 1991

90. C. Ezeamuzie. M. Al-Hage: Effects of some anti-asthma drugs on human eosinophile superoxide anions release and degranulation; Int Arch Allergy Immunol 115; 162-168; 1993

91 . R. Crameri, A. Faith, S. Hemmann, R. Jaussi, C. Ismail, G. Menz, K. Blaser: Human cell-mediated autoimmunity in allergy to Aspergillus fumigatus; J Exp Med 184; 265-267; 1995

92 . P. Wang, H. Chen, H. Qin, S. Sankarapandi, M.W. Becher, P.C. Wong, J.L. Zangh: Overexpression of human copper, zinc-superoxide dismutase (SOD-1) prevents postischemic injury; Proc Natl Acad Sci 95; 4556-4560; 1998

93. I. Petyaev, M.J.M. Mitchinson, J. Hunt, P.J. Coussons: Superoxide dismutase antibodies purified from the human arteries and artherosclerotic lesions; Biochem Soc J; 43; 1998

94 . M.B. Mihailovic, D.M. Avramovic, I.B. Jovanovic, O.J. Pesut, D.P. Matic, V.J. Stojanov: Blood plasma selenium levels and GPX-3 activities in patients with arterial hypertension and chronic heart disease; J Environ Pathol Toxicol Oncol 17(3-4); 285-289; 1998


[Seite 95↓]

95 . M.A. Dubick, C.L. Keen, R.A. DiSilvestro, C.D. Eskelson, J. Ireton: Antioxidant enzyme activity in human abdominal aortic aneurysmal and occlusive disease; Proc Soc Exp Biol Med 220(1); 39-45; 1999

96 . J. Götz, C.I. va Kan, H.W. Verspaget, I. Biemond, C.B. Lamers, R.A. Veenert: Gastric mucosal superoxide dismutases in Helicobacter pylori infection; Gut 38; 502-505; 1998

97. H.P. Monteiro, E.J. Bechara, D.S. Abdalla: Free radicals involvement in neurological porphyrias and leading to poisoning; Mol Cell Biochem 103(1); 73-83; 1991

98 . A. Seven, Y. Erbil, R. Seven, F. Inci, T. Gulyasar, B. Barutcu, G. Candan: Breast cancer and benign breast disease patients evaluated in relation to oxidative stress; Cancer Biochem Biophys 16(4); 333-345; 1998

99 . T. Mano, R. Shinohara, K. Iwase, M. Kotake, M. Hamada, K. Uchimuro, N. Hayakawa, R. Hayashi, A. Nakai, Y. Ishizuki, A. Nagasaka: Changes in free radicals scavengers and lipid peroxide in thyroid glands of various thyroid disorders; Horm Metab Res 29(7); 351-354; 1997

100 . S. Turi, I. Nemeth, A. Torkos, L. Saghy, I Varga, B. Matkovics, J. Nagy: Oxidative stress and antioxidant defense mechanism in glomerular diseases; Free Radic Biol Med 22(1-2); 161-168; 1997

101 . R. Malmgren, G. Unge, O. Zetterström, H. Theorell, K. De Wahl: Lowered glutathione-peroxidase activity in asthmatic patients with food and aspirin intolerance; DNA Cell Biol 41; 43-45; 1986

102 . A.H. Abou Ghalia, I.M. Fouad: Glutathione and its metabolizing enzymes in patients with different benign and malignant diseases; Clin Biochem 33(8); 657-662; 2000

103 . A. Furuta, D.L. Price, C.A. Pardo, J.C. Troncoso, Z.S. Xu, N. Taniguchi: Localization of superoxide dismutase in Alzheimer´s disease and Down´s syndrome in substantia nigra and hippocampus; Am J Pathol 146; 357-367; 1995

104. D. Price, S.S. Sangram, D.R. Borchelt: Theories of illness and transgenic models; Science 286; 1079-1083; 1998

105 . D. Offen, P.M. Beart, N.S. Cheung, C.J. Pascoe, A. Hochman, S. Gorodin, E.M. Bernard, O. Bernard: Transgenic mice expressing human Bcl-2 are vulnerable to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity; Acad Sci 95; 5789-5794; 1998

106 . C.J. Cunnings, H.Y. Zoghbi: Fourteen and counting: unraveling trinucleotide repeat dieseases; Hum Mol Genet 9 (6); 909-916; 2000

107 . K. Usdin, E. Grabczyk: DNA repeat expansions and human disease; Cell Mol Life Sci 57(6); 914-931; 2000

108 . B.L. Sopher, S.B. Myrick, J.Y. Hong, A.C. Smith, A.R. La Spada: In vivo expansion of trinucleotide repeats yields plasmid and YAC constructs for targeting and transgenesis; Gene 261(2); 383-390; 2000


[Seite 96↓]

109 . A.P. Lieberman, K.H. Fischbeck: Triplet repeat expansion in neuromuscular disease; Muscle & Nerve 23; 843-850; 2000

110 . P. Baldi, S. Brunak, Y. Chauvin, A.G. Pedersen : Structural basis for triplet repeat disorders: a computational analysis; Bioinformatics 15(11); 918-929; 1999

111. V. Meininger: Getting the diagnosis right: beyond El Escorial; J Neurol 246(3); 1999

112 . B.J. Traynor, M.B. Codd, B. Corr, C. Forde, E. Frost, O.M. Hardiman: Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria; Arch Neurol 57; 1171-1176; 2000

113 . H.T. Orr, H.Y. Zoghbi : Polyglutamine tract vs. protein context in SCA1 pathogenesis. In D.C. Rubinsztein und MR. Hayden: Analysis of triplet repeat disorders; BIOS; Oxford; 105-118; 1998

114 . H. Moore, P.W. Greenwell, C.-P. Liu, N. Arnheim, T.D. Peters: Triplet repeats form secondary structures that escape DNA repair in yeast; Proc Natl. Acad. Sci 96(4); 1504-1509; 1999

115 . R.R. Sinden: Biological implications of the DNA structures associated with disease-causing triplet repeats; Am J Hum Genet 64; 346-353; 1999

116. P.D. Chastain, R.R. Sinden : CTG repeats associated with human genetic disease are inherently flexible; J Mol Biol 275; 405-411; 1998

117 . Y.-H. Wang, R. Gellibolian, M. Shimizu, R.D. Wells, J. Griffith: Long CCG triplet repeat blocks exclude nucleosomes – a possible mechanism for the nature of fragile sites in chromosomes; J Mol Biol 263 ; 511-516; 1996

118 . D. Suck: DNA recognition by Dnase I ; J Mol Recognition 7; 65-70; 1994

119 . L. Forsberg, U. de Faire, S.L. Marklund, P.M. Andersson, B. Stegmayr, R. Morgenstern: Phenotype determination of a common Pro-Leu polymorphism i human glutahione peroxidase 1; Blood Cells, Molecules and Diseases; 26(5); 423-426; 2000

120 . T.A. Glauser, M. Titanic-Schefft; C.E. Pippenger: Racial differences in free radical scavenging enzyme activity in children; J Child Neurol; 14(6); 382-387; 1999

121 . E. Beutler, C. West, B. Beutler; Electrophoretic polymorphism of glutathione peroxidase; Ann Hum Genet 38; 163-169; 1974

122 . P. Meera Khan, C. Verma, L.M. Wijnen, S. Jairaj: Red cell glutathione peroxidase (GPX1) variation in Afro-Jamaican, Asiatic-Indian and Dutch population. Is the GPX 1*2 allele of “Thomas” variant an African marker? Hum Genet 66(4); 352-355; 1999


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
25.11.2003